https://www.sciencedaily.com/news/health_medicine/prostate_health/ Latest research news on prostate health. Find out about prostate cancer symptoms, enlarged prostate and other prostate problems. en-us Fri, 06 Mar 2026 01:58:55 EST Fri, 06 Mar 2026 01:58:55 EST 60 https://www.sciencedaily.com/images/scidaily-logo-rss.png https://www.sciencedaily.com/news/health_medicine/prostate_health/ For more science news, visit ScienceDaily. https://www.sciencedaily.com/releases/2026/02/260203030537.htm Scientists are digging into why heart disease risk in type 2 diabetes differs between men and women—and sex hormones may be part of the story. In a large Johns Hopkins study, men with higher testosterone had lower heart disease risk, while rising estradiol levels were linked to higher risk. These hormone effects were not seen in women. The results point toward more personalized approaches to heart disease prevention in diabetes. Wed, 04 Feb 2026 02:21:09 EST https://www.sciencedaily.com/releases/2026/02/260203030537.htm https://www.sciencedaily.com/releases/2026/01/260120000323.htm Ibuprofen may be doing more than easing aches and pains—it could also help reduce the risk of some cancers. Studies have linked regular use to lower rates of endometrial and bowel cancer, likely because the drug dampens inflammation that fuels tumor growth. Researchers have even found it can interfere with genes cancer cells rely on to survive. Still, experts warn that long-term use carries risks and shouldn’t replace proven prevention strategies. Tue, 20 Jan 2026 03:47:11 EST https://www.sciencedaily.com/releases/2026/01/260120000323.htm https://www.sciencedaily.com/releases/2025/12/251228020016.htm Researchers discovered that clogged brain “drains” show up early in people at risk of Alzheimer’s disease. These blockages, easily seen on standard MRI scans, are tied to toxic protein buildup linked to memory loss and cognitive decline. In some cases, they may signal Alzheimer’s earlier than other commonly used brain markers. This could help physicians detect the disease earlier, before irreversible damage sets in. Sat, 03 Jan 2026 00:45:11 EST https://www.sciencedaily.com/releases/2025/12/251228020016.htm https://www.sciencedaily.com/releases/2025/10/251021083642.htm A powerful new drug combination—niraparib added to standard prostate cancer therapy—has been shown to significantly delay disease progression in men with specific DNA repair gene mutations. In the large AMPLITUDE trial, patients receiving the combo lived longer without symptoms worsening and saw nearly a 50% risk reduction in BRCA-mutated cases. While side effects like anemia were more common, the results mark a major step toward precision medicine for prostate cancer. Tue, 21 Oct 2025 22:53:19 EDT https://www.sciencedaily.com/releases/2025/10/251021083642.htm https://www.sciencedaily.com/releases/2025/09/250914205832.htm Eye drops combining pilocarpine and diclofenac helped patients read extra lines on vision charts, with effects lasting up to two years. The treatment could revolutionize presbyopia care as a safe, non-surgical alternative to glasses. Mon, 15 Sep 2025 01:23:48 EDT https://www.sciencedaily.com/releases/2025/09/250914205832.htm https://www.sciencedaily.com/releases/2025/09/250908175446.htm UC Berkeley researchers mapped the brain circuits that control growth hormone during sleep, uncovering a feedback system where sleep fuels hormone release, and the hormone regulates wakefulness. The discovery helps explain links between poor sleep, obesity, diabetes, and cognitive decline, while opening new paths for treating sleep and metabolic disorders. Mon, 08 Sep 2025 22:23:46 EDT https://www.sciencedaily.com/releases/2025/09/250908175446.htm https://www.sciencedaily.com/releases/2025/05/250520121154.htm Head and neck cancer researchers are reporting the development and testing of HPV-DeepSeek, a novel liquid biopsy assay. In their new study, HPV-DeepSeek achieved 99% sensitivty and specifity for diagnosing HPV-associated head and neck cancers, outperforming standard of care methods. HPV causes about 70% of oropharyngeal cancers in the U.S., which are increasing in incidence faster than other head and neck cancers. Tue, 20 May 2025 12:11:54 EDT https://www.sciencedaily.com/releases/2025/05/250520121154.htm https://www.sciencedaily.com/releases/2025/05/250513150241.htm Hormone levels fluctuate like the tides, ebbing and flowing according to carefully orchestrated cycles. These hormones not only influence the body, but can cross into the brain and shape the behavior of our neurons and cognitive processes. Recently, researchers used modern laser microscopy techniques to observe how fluctuations in ovarian hormones shape both the structure and function of neurons in the mouse hippocampus, a brain region crucial for memory formation and spatial learning in mammals. They found that hormone fluctuations during the mouse estrous cycle, a 4-day cycle analogous to the 28-day human menstrual cycle, powerfully influence the shape and behavior of hippocampal neurons. Tue, 13 May 2025 15:02:41 EDT https://www.sciencedaily.com/releases/2025/05/250513150241.htm https://www.sciencedaily.com/releases/2025/05/250513112451.htm Researchers have conducted a clinical study to show how a woman's genetic profile provides information on which hormone treatment is most effective for in vitro fertilization (IVF). The researchers have now developed a simple oral swab test that shows which hormone therapy is the best option for IVF treatment. Tue, 13 May 2025 11:24:51 EDT https://www.sciencedaily.com/releases/2025/05/250513112451.htm https://www.sciencedaily.com/releases/2025/04/250422131542.htm Oral hormone therapy may benefit heart health in menopausal women. A new analysis of data from the Women's Health Initiative found that estrogen-based oral hormone therapy had a long-term beneficial effect on biomarkers of cardiovascular health, including cholesterol. Tue, 22 Apr 2025 13:15:42 EDT https://www.sciencedaily.com/releases/2025/04/250422131542.htm https://www.sciencedaily.com/releases/2025/03/250310201805.htm Prostate cancer statistics can look scary: 34,250 U.S. deaths in 2024. 1.4 million new cases worldwide in 2022. Mon, 10 Mar 2025 20:18:05 EDT https://www.sciencedaily.com/releases/2025/03/250310201805.htm https://www.sciencedaily.com/releases/2025/03/250306121253.htm New research is studying female professional footballers to find out if if it is possible to predict just how much lactate a person will produce during exercise based on the physical attributes of finger length and height. Thu, 06 Mar 2025 12:12:53 EST https://www.sciencedaily.com/releases/2025/03/250306121253.htm https://www.sciencedaily.com/releases/2025/02/250221125757.htm Using the microscopic structures found on the wings of the Morpho butterfly, researchers have developed a simple and inexpensive way to analyze cancer biopsy samples that could make cancer diagnosis faster, more accurate and more accessible worldwide. Fri, 21 Feb 2025 12:57:57 EST https://www.sciencedaily.com/releases/2025/02/250221125757.htm https://www.sciencedaily.com/releases/2025/02/250213144326.htm Testosterone treatment significantly reduces mortality among men with Klinefelter syndrome. Researcher calls for changes in guidelines to ensure more patients receive the necessary treatment. Thu, 13 Feb 2025 14:43:26 EST https://www.sciencedaily.com/releases/2025/02/250213144326.htm https://www.sciencedaily.com/releases/2025/02/250210133016.htm Breast cancers at all stages are defined by the structure of their genomes, researchers find. Targeting these processes early is likely to offer unexpected therapeutic avenues. Mon, 10 Feb 2025 13:30:16 EST https://www.sciencedaily.com/releases/2025/02/250210133016.htm https://www.sciencedaily.com/releases/2024/12/241219152421.htm There are several strategies for the early detection of prostate cancer. The first step is often a blood test for prostate-specific antigen (PSA). If PSA levels exceed a certain threshold, the next step typically involves taking a tissue sample for analysis. Another option is to use magnetic resonance imaging (MRI) to search for signs of a tumor before deciding whether a biopsy is necessary, reserving biopsies only for cases where abnormalities are detected. Researchers at conducted a study to determine whether this MRI-first approach is safe over the long term. Their findings show that this strategy poses no additional risk to patients for at least three years. Thu, 19 Dec 2024 15:24:21 EST https://www.sciencedaily.com/releases/2024/12/241219152421.htm https://www.sciencedaily.com/releases/2024/12/241213125155.htm A new review reveals how your DNA shapes reproductive health, fertility, and even life expectancy. Fri, 13 Dec 2024 12:51:55 EST https://www.sciencedaily.com/releases/2024/12/241213125155.htm https://www.sciencedaily.com/releases/2024/11/241128124501.htm New research shows that long-term sex hormone treatment in transgender individuals can lead to significant changes in body composition and risk factors for cardiovascular disease, particularly in transgender men. Thu, 28 Nov 2024 12:45:01 EST https://www.sciencedaily.com/releases/2024/11/241128124501.htm https://www.sciencedaily.com/releases/2024/11/241127191932.htm Researchers have analysed the effects of seven different hormone treatments for menopausal symptoms on the risk of blood clots, stroke and heart attack. The study, which involved around one million women aged between 50 and 58, is the largest and most comprehensive study of currently prescribed hormonal substances in the world. The results show that the risks differ depending on the active substance and how the medicine is taken. Wed, 27 Nov 2024 19:19:32 EST https://www.sciencedaily.com/releases/2024/11/241127191932.htm https://www.sciencedaily.com/releases/2024/11/241126145338.htm There is evidence that alcohol consumption is influenced by prenatal sex steroids, so experts decided to use a sample of students for their research into the subject. Tue, 26 Nov 2024 14:53:38 EST https://www.sciencedaily.com/releases/2024/11/241126145338.htm https://www.sciencedaily.com/releases/2024/10/241017173152.htm Researchers have developed strategies to identify regulators of intestinal hormone secretion. In response to incoming food, these hormones are secreted by rare hormone producing cells in the gut and play key roles in managing digestion and appetite. The team has developed new tools to identify potential 'nutrient sensors' on these hormone producing cells and study their function. This could result in new strategies to interfere with the release of these hormones and provide avenues for the treatment of a variety of metabolic or gut motility disorders. Thu, 17 Oct 2024 17:31:52 EDT https://www.sciencedaily.com/releases/2024/10/241017173152.htm https://www.sciencedaily.com/releases/2024/09/240925143915.htm A new study sheds light on testosterone recovery following androgen deprivation therapy (ADT) in men undergoing radiotherapy for prostate cancer, providing key insights for optimizing patient care. Wed, 25 Sep 2024 14:39:15 EDT https://www.sciencedaily.com/releases/2024/09/240925143915.htm https://www.sciencedaily.com/releases/2024/09/240923110802.htm A new preclinical model using CRISPR, an advanced technology that allows scientists to cut and edit genes, has given researchers a deeper insight into how prostate cancer spreads or metastasizes. Mon, 23 Sep 2024 11:08:02 EDT https://www.sciencedaily.com/releases/2024/09/240923110802.htm https://www.sciencedaily.com/releases/2024/09/240919174810.htm A multi-institutional clinical trial showed that a newer technique for collecting prostate biopsy samples reduced the risk of infection compared with traditional biopsy approaches. Thu, 19 Sep 2024 17:48:10 EDT https://www.sciencedaily.com/releases/2024/09/240919174810.htm https://www.sciencedaily.com/releases/2024/09/240904184536.htm A treatment paradox has recently come to light in prostate cancer: blocking testosterone production halts tumor growth in early disease, while elevating the hormone can delay disease progression in patients whose disease has advanced. The inability to understand how different levels of the same hormone can drive different effects in prostate tumors has been an impediment to the development of new therapeutics that exploit this biology. Wed, 04 Sep 2024 18:45:36 EDT https://www.sciencedaily.com/releases/2024/09/240904184536.htm https://www.sciencedaily.com/releases/2024/09/240904130807.htm Researchers have uncovered how hormones profoundly affect our immune systems, explaining why men and women are affected by diseases differently. Wed, 04 Sep 2024 13:08:07 EDT https://www.sciencedaily.com/releases/2024/09/240904130807.htm https://www.sciencedaily.com/releases/2024/08/240822125901.htm The anti-cancer drug olaparib may be effective in treating biochemically recurrent prostate cancer without accompanying hormone therapy for men who have mutations in genes such as BRCA2, according to results of a phase II clinical trial of 51 patients. Thu, 22 Aug 2024 12:59:01 EDT https://www.sciencedaily.com/releases/2024/08/240822125901.htm https://www.sciencedaily.com/releases/2024/08/240822125859.htm Research in mice sheds light on how thyroid hormone alters wiring in the brain. Findings reveal that thyroid hormone syncs up the brain and body to drive exploratory behavior. Researchers say their work could illuminate new treatments for certain psychiatric conditions. Thu, 22 Aug 2024 12:58:59 EDT https://www.sciencedaily.com/releases/2024/08/240822125859.htm https://www.sciencedaily.com/releases/2024/08/240820124511.htm Scientists are finding clues for how to treat diabetes and hormone disorders in an unexpected place: a toxin from one of the most venomous animals on the planet. Tue, 20 Aug 2024 12:45:11 EDT https://www.sciencedaily.com/releases/2024/08/240820124511.htm https://www.sciencedaily.com/releases/2024/08/240820124451.htm Men with metastatic castration-resistant prostate cancer should be treated primarily with second-generation hormone drugs, which offer better treatment response and longer life expectancy than chemotherapy. However, the effect depends on which mutations the patient's tumor carries, according to a new study. Tue, 20 Aug 2024 12:44:51 EDT https://www.sciencedaily.com/releases/2024/08/240820124451.htm https://www.sciencedaily.com/releases/2024/08/240814124544.htm Being born in autumn or winter is associated with asthma and allergic rhinitis in Finland, a new registry-based study shows. Wed, 14 Aug 2024 12:45:44 EDT https://www.sciencedaily.com/releases/2024/08/240814124544.htm https://www.sciencedaily.com/releases/2024/08/240809135718.htm A new study has revealed important information about how a patient's testosterone level can help protect them from severe COVID-19. Researchers have been working to look more closely at the subject and their findings could have significant implications for public health and future treatments. Fri, 09 Aug 2024 13:57:18 EDT https://www.sciencedaily.com/releases/2024/08/240809135718.htm https://www.sciencedaily.com/releases/2024/07/240729172946.htm A new study has found that people with newly diagnosed OA (knee or hip) with contraindications to or precautions for NSAIDs use continue to be prescribed these drugs. Additionally they had higher use of opioids and slightly lower physical therapy (PT) use within the first year of OA diagnosis, both of which are not consistent with treatment guidelines for OA. Mon, 29 Jul 2024 17:29:46 EDT https://www.sciencedaily.com/releases/2024/07/240729172946.htm https://www.sciencedaily.com/releases/2024/07/240709121656.htm A recent study examined data from more than 10,000 patients with 'Biopsy Gleason Grade Group (GGG) 1,' a diagnosis considered to be the lowest grade cancer. Researchers found that even among patients diagnosed using the most modern diagnostic approach, 8 percent of patients with GGG1 had high-risk prostate cancer. Two risk factors -- high PSA levels and the presence of 50 percent or more positive biopsies from sampling -- could help identify patients with GGG1 at greatest risk of aggressive prostate cancer and increased risk of death. Tue, 09 Jul 2024 12:16:56 EDT https://www.sciencedaily.com/releases/2024/07/240709121656.htm https://www.sciencedaily.com/releases/2024/06/240620152309.htm Women who have their ovaries removed before menopause, particularly before the age of 40, have reduced white matter integrity in multiple regions of the brain later in life, a new study suggests. White matter refers to the nerve fibers that connect neurons in different areas of the brain. Thu, 20 Jun 2024 15:23:09 EDT https://www.sciencedaily.com/releases/2024/06/240620152309.htm https://www.sciencedaily.com/releases/2024/06/240614155434.htm Researchers have consistently shown that prenatal exposure to Di (2-ethyhexyl) phthalate harms the reproductive system in male mice and causes fertility defects. In a new study, scientists have shown that the combination of DEHP and a high-fat diet in pregnant mice can cause more damage to pups than each factor alone. Fri, 14 Jun 2024 15:54:34 EDT https://www.sciencedaily.com/releases/2024/06/240614155434.htm https://www.sciencedaily.com/releases/2024/05/240530132331.htm Amid growing awareness of transgender healthcare challenges, a pressing need arises for comprehensive studies on the safety and efficacy of gender-affirming hormone therapy for transgender men. Now, researchers have studied the long-term effects and safety profile of testosterone therapy for transgender men. The findings highlight the favorable outcomes of both low and high-dose testosterone regimens, providing valuable insights for clinicians and empowering transgender individuals to make informed treatment decisions. Thu, 30 May 2024 13:23:31 EDT https://www.sciencedaily.com/releases/2024/05/240530132331.htm https://www.sciencedaily.com/releases/2024/04/240418111744.htm Researchers have developed a new urine-based test that addresses a major problem in prostate cancer: how to separate the slow-growing form of the disease unlikely to cause harm from more aggressive cancer that needs immediate treatment. Thu, 18 Apr 2024 11:17:44 EDT https://www.sciencedaily.com/releases/2024/04/240418111744.htm https://www.sciencedaily.com/releases/2024/03/240311145825.htm Scientists trained a machine-learning algorithm to predict accurately brain metastasis using biopsy samples from early-stage non-small cell lung cancer patients. It was also highly accurate in predicting those patients who do not develop metastatic brain tumors. Mon, 11 Mar 2024 14:58:25 EDT https://www.sciencedaily.com/releases/2024/03/240311145825.htm https://www.sciencedaily.com/releases/2024/02/240220203309.htm The drug finasteride, also known as Propecia or Proscar, treats male pattern baldness and enlarged prostate in millions of men worldwide. But a new study suggests the drug may also provide a surprising and life-saving benefit: lowering cholesterol and cutting the overall risk of cardiovascular disease. Tue, 20 Feb 2024 20:33:09 EST https://www.sciencedaily.com/releases/2024/02/240220203309.htm https://www.sciencedaily.com/releases/2024/02/240213130443.htm People using anabolic steroids could be increasing their underlying risk of a heart condition called atrial fibrillation, according to a new study. Tue, 13 Feb 2024 13:04:43 EST https://www.sciencedaily.com/releases/2024/02/240213130443.htm https://www.sciencedaily.com/releases/2024/02/240201121851.htm Research throws light on the mystery of why women are much more prone to autoimmune disorders: A molecule made by one X chromosome in every female cell can generate antibodies to a woman's own tissues. Thu, 01 Feb 2024 12:18:51 EST https://www.sciencedaily.com/releases/2024/02/240201121851.htm https://www.sciencedaily.com/releases/2024/01/240123175430.htm Combining testosterone-blocking drugs in patients with prostate cancer relapse prevents the spread of cancer better than treatment with a single drug, a multi-institution, Phase 3 clinical trial has found. Tue, 23 Jan 2024 17:54:30 EST https://www.sciencedaily.com/releases/2024/01/240123175430.htm https://www.sciencedaily.com/releases/2024/01/240122144432.htm A groundbreaking study has unveiled a significant link between anxiety disorders and a brain receptor known as TACR3, as well as testosterone. Mon, 22 Jan 2024 14:44:32 EST https://www.sciencedaily.com/releases/2024/01/240122144432.htm https://www.sciencedaily.com/releases/2024/01/240110120221.htm Researchers have developed a blood test that can reliably detect neuroendocrine prostate cancer and differentiate it from castration-resistant prostate cancer-adenocarcinoma (CRPC-adeno). Wed, 10 Jan 2024 12:02:21 EST https://www.sciencedaily.com/releases/2024/01/240110120221.htm https://www.sciencedaily.com/releases/2024/01/240102142019.htm Researchers have found that enlarged perivascular spaces in the brains of babies, caused by an accumulation of excess cerebrospinal fluid, have a 2.2 times greater chance of developing autism later in life. Tue, 02 Jan 2024 14:20:19 EST https://www.sciencedaily.com/releases/2024/01/240102142019.htm https://www.sciencedaily.com/releases/2023/12/231214131751.htm Using cells from kidney biopsies, researchers report progress in the search for more accurate and easier-to-obtain markers to help predict, manage and assess treatment of acute kidney injury (AKI). Marked by serious inflammation, AKI can lead to sudden loss of kidney function, and clinicians have long searched for markers that alert them to AKI status without the need for invasive kidney biopsies. Thu, 14 Dec 2023 13:17:51 EST https://www.sciencedaily.com/releases/2023/12/231214131751.htm https://www.sciencedaily.com/releases/2023/12/231213112510.htm A new study has shown why many women experience nausea and vomiting during pregnancy -- and why some women, including the Duchess of Cambridge, become so sick they need to be admitted to hospital. The culprit is a hormone produced by the fetus -- a protein known as GDF15. But how sick the mother feels depends on a combination of how much of the hormone is produced by the fetus and how much exposure the mother had to this hormone before becoming pregnant. Wed, 13 Dec 2023 11:25:10 EST https://www.sciencedaily.com/releases/2023/12/231213112510.htm https://www.sciencedaily.com/releases/2023/12/231204135037.htm Two new studies give insight into how cells use energy to influence the way prostate tumors survive and grow -- advancements that can help explain why some prostate cancers become resistant to hormone therapy, the most commonly used treatment for men with advanced stages of the disease. Mon, 04 Dec 2023 13:50:37 EST https://www.sciencedaily.com/releases/2023/12/231204135037.htm https://www.sciencedaily.com/releases/2023/11/231127132454.htm A common concern about gender-affirming hormone therapy for transmasculine people is the risk of red blood cell volume changes and erythrocytosis, a high concentration of red blood cells, with the use of prescribed testosterone. However, researchers have found that testosterone treatment may be safer than previously reported. Mon, 27 Nov 2023 13:24:54 EST https://www.sciencedaily.com/releases/2023/11/231127132454.htm https://www.sciencedaily.com/releases/2023/11/231108154159.htm Studies exploring metformin's power to prevent prostate cancer progression have been inconclusive. Research now shows that the drug has promise, but only for specific patients. Wed, 08 Nov 2023 15:41:59 EST https://www.sciencedaily.com/releases/2023/11/231108154159.htm https://www.sciencedaily.com/releases/2023/10/231018194545.htm Investigators have identified two promising new treatment options for men with recurrent prostate cancer -- both of which helped patients live longer without their disease progressing than the current standard treatment. 'If these treatments are approved by the Food and Drug Administration, our results will be practice changing,' said Stephen Freedland, MD, associate director for Training and Education and the Warschaw, Robertson, Law Families Chair in Prostate Cancer at Cedars-Sinai, and lead author of the study. 'In the study, both of these new options improved metastasis-free survival while preserving quality of life.' Wed, 18 Oct 2023 19:45:45 EDT https://www.sciencedaily.com/releases/2023/10/231018194545.htm https://www.sciencedaily.com/releases/2023/09/230907105759.htm The ketogenic (keto) diet may lower testosterone levels in women with polycystic ovary syndrome (PCOS), according to a new article. Thu, 07 Sep 2023 10:57:59 EDT https://www.sciencedaily.com/releases/2023/09/230907105759.htm https://www.sciencedaily.com/releases/2023/09/230905124856.htm Female kidneys are known to be more resilient to disease and injury, but a new study may help researchers better understand how to address sex-related health disparities for patients with kidney diseases. The study describes not only how sex hormones drive differences in male and female mouse kidneys, but also how lowering testosterone can 'feminize' this organ and improve its resilience. Tue, 05 Sep 2023 12:48:56 EDT https://www.sciencedaily.com/releases/2023/09/230905124856.htm https://www.sciencedaily.com/releases/2023/08/230831121621.htm A lab is developing more accurate and powerful liquid biopsy technologies that take advantage of signals from RNA 'dark matter,' an understudied area of the genome. Thu, 31 Aug 2023 12:16:21 EDT https://www.sciencedaily.com/releases/2023/08/230831121621.htm https://www.sciencedaily.com/releases/2023/08/230821232426.htm Using MRI as a screening test alongside PSA density allowed detection of cancers that would have been missed by the blood test alone, according to new research. Mon, 21 Aug 2023 23:24:26 EDT https://www.sciencedaily.com/releases/2023/08/230821232426.htm https://www.sciencedaily.com/releases/2023/08/230814122244.htm A study uncovers a new mechanism to explain why some prostate tumors switch from a common, treatable form to a more rare and aggressive form of prostate cancer. Mon, 14 Aug 2023 12:22:44 EDT https://www.sciencedaily.com/releases/2023/08/230814122244.htm https://www.sciencedaily.com/releases/2023/07/230728170611.htm A new study of cadmium in pregnant women yields crucial insights into the placenta's role in regulating toxin exposure. Fri, 28 Jul 2023 17:06:11 EDT https://www.sciencedaily.com/releases/2023/07/230728170611.htm https://www.sciencedaily.com/releases/2023/07/230721113111.htm Around one third of people with heart disease suffer from sleep problems. A team now shows that heart diseases affect the production of the sleep hormone melatonin in the pineal gland. The link between the two organs is a ganglion in the neck region. The study demonstrates a previously unknown role of ganglia and points to possible treatments. Fri, 21 Jul 2023 11:31:11 EDT https://www.sciencedaily.com/releases/2023/07/230721113111.htm https://www.sciencedaily.com/releases/2023/07/230707111648.htm A new study suggests that birth-control pills negatively impact women's stress response. Fri, 07 Jul 2023 11:16:48 EDT https://www.sciencedaily.com/releases/2023/07/230707111648.htm